avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Cebpd
|
ENSMUSG00000071637.4 | CCAAT/enhancer binding protein (C/EBP), delta |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 6.1 | GO:2001293 | fatty-acyl-CoA biosynthetic process(GO:0046949) malonyl-CoA metabolic process(GO:2001293) |
1.2 | 5.8 | GO:0006548 | histidine catabolic process(GO:0006548) |
1.0 | 58.1 | GO:0006953 | acute-phase response(GO:0006953) |
1.0 | 11.2 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
1.0 | 7.8 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.8 | 2.5 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.8 | 3.4 | GO:0016259 | selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
0.8 | 5.0 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.8 | 6.4 | GO:0097460 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.7 | 5.1 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
0.6 | 1.9 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.6 | 1.8 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.5 | 2.0 | GO:0021664 | rhombomere formation(GO:0021594) rhombomere 3 formation(GO:0021660) rhombomere 5 morphogenesis(GO:0021664) rhombomere 5 formation(GO:0021666) |
0.5 | 3.6 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.4 | 2.6 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.3 | 1.2 | GO:0071931 | positive regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071931) positive regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0090282) |
0.3 | 9.8 | GO:0006825 | copper ion transport(GO:0006825) |
0.3 | 1.4 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.2 | 3.7 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.2 | 8.3 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.2 | 2.1 | GO:0006983 | ER overload response(GO:0006983) |
0.2 | 0.8 | GO:0071623 | negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) |
0.2 | 0.6 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.2 | 1.7 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 0.4 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.1 | 0.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 6.5 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.1 | 1.6 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 2.9 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 2.7 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 | 8.9 | GO:0031638 | zymogen activation(GO:0031638) |
0.1 | 0.2 | GO:0051866 | general adaptation syndrome(GO:0051866) |
0.1 | 1.4 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 1.8 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.0 | 0.8 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.0 | 4.5 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.0 | 0.7 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.0 | 15.2 | GO:0032259 | methylation(GO:0032259) |
0.0 | 0.7 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.5 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.2 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.0 | 2.1 | GO:0048041 | cell-substrate adherens junction assembly(GO:0007045) focal adhesion assembly(GO:0048041) |
0.0 | 0.7 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.0 | 0.7 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.0 | 0.8 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 11.2 | GO:0043203 | axon hillock(GO:0043203) |
0.6 | 6.4 | GO:0097433 | dense body(GO:0097433) |
0.6 | 22.0 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.5 | 1.4 | GO:0043512 | inhibin A complex(GO:0043512) |
0.4 | 1.8 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.6 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 19.8 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 1.2 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 5.8 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 2.1 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.8 | GO:0005685 | U1 snRNP(GO:0005685) |
0.0 | 2.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 1.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 41.1 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 2.1 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 2.5 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 5.1 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
1.2 | 3.7 | GO:0050479 | glyceryl-ether monooxygenase activity(GO:0050479) |
1.2 | 6.1 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
1.1 | 7.8 | GO:0001851 | complement component C3b binding(GO:0001851) |
0.9 | 6.4 | GO:0072510 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
0.8 | 5.8 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.7 | 7.2 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.7 | 22.0 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.6 | 2.5 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.6 | 3.6 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.5 | 5.0 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.3 | 2.6 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.2 | 1.4 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.2 | 0.8 | GO:0001847 | opsonin receptor activity(GO:0001847) |
0.2 | 0.6 | GO:0019981 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
0.2 | 0.8 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.2 | 15.2 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.1 | 2.7 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 1.7 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
0.1 | 8.3 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 2.9 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 1.4 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 13.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 4.5 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 0.5 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.4 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 2.0 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 8.9 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 1.2 | GO:0001223 | RNA polymerase II core binding(GO:0000993) transcription coactivator binding(GO:0001223) |
0.0 | 0.6 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 2.1 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 1.8 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 2.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 1.6 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.2 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 5.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 7.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 17.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 1.4 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 7.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 2.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 1.8 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.8 | PID E2F PATHWAY | E2F transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 5.7 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.6 | 8.9 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.6 | 7.8 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 6.1 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.2 | 7.2 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.2 | 15.5 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.2 | 1.4 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 0.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 5.1 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 4.5 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 5.0 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 2.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 1.8 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 1.8 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 5.8 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 1.6 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 2.0 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 1.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 3.6 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |